Literature DB >> 30848494

Naltrexone Acutely Enhances Connectivity Between the Ventromedial Prefrontal Cortex and a Left Frontoparietal Network.

Amanda Elton1,2, Samantha Dove1, Cory N Spencer1, Donita L Robinson2,3, Charlotte A Boettiger1,2,4.   

Abstract

BACKGROUND: Naltrexone, an opioid receptor antagonist that is Food and Drug Administration approved for treating alcohol use disorder (AUD), reduces alcohol craving and intake. Despite known pharmacological properties, little is known regarding the effects of naltrexone on neural circuit function. Thus, a data-driven examination of the neural effects of naltrexone in human subjects may offer novel insight into its treatment mechanisms.
METHODS: Twenty-one alcohol using males (22 to 39) participated in a double-blind, placebo-controlled crossover study of the effects of naltrexone on brain voxel-wise functional connectivity (FC) using intersubject FC correlation mapping. We first cross-correlated the time series from each gray matter voxel to produce a 6,356 × 6,356 FC matrix for each subject and session. We then subtracted the placebo FC matrix from the naltrexone FC matrix. To identify brain regions demonstrating significant reconfiguration of whole-brain FC patterns following naltrexone treatment, we statistically quantified the consistency of patterns of voxel FC changes across subjects. Permutation testing identified significant clusters of voxels undergoing significant reconfiguration. Using the identified clusters in a seed-based FC analysis, we then compared the FC patterns of affected brain areas on placebo versus naltrexone in a paired t-test. Ridge regression analyses identified self-report measures, including substance use, that significantly predicted individual differences in FC among naltrexone-modulated regions.
RESULTS: Two clusters in the rostral anterior cingulate cortex (rACC)/ventromedial prefrontal cortex (vmPFC) demonstrated significant modulation of FC by naltrexone. Using these 2 proximal clusters as a single seed, specific FC changes were identified in regions associated with a left frontoparietal network (increasing), as well as visual and motor regions (decreasing). Stronger FC between the rACC/vmPFC and this set of regions on placebo was associated with more external locus of control, whereas weaker connectivity was associated with greater substance use problems. Naltrexone strengthened these connections most among individuals who reported greater drinking to cope.
CONCLUSIONS: Enhancing connectivity between the rACC/vmPFC, implicated in alcohol craving, and components of a left frontoparietal network involved in executive control may represent an effective strategy for the treatment of AUD.
© 2019 by the Research Society on Alcoholism.

Entities:  

Keywords:  Medial Prefrontal Cortex; Naltrexone; Resting State; fMRI

Mesh:

Substances:

Year:  2019        PMID: 30848494      PMCID: PMC6528472          DOI: 10.1111/acer.13999

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  100 in total

1.  AFNI: software for analysis and visualization of functional magnetic resonance neuroimages.

Authors:  R W Cox
Journal:  Comput Biomed Res       Date:  1996-06

2.  Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking.

Authors:  Amy W Helstrom; Frederick C Blow; Valerie Slaymaker; Henry R Kranzler; Shirley Leong; David Oslin
Journal:  Alcohol Alcohol       Date:  2016-07-11       Impact factor: 2.826

Review 3.  Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.

Authors:  Lara A Ray; Pauline F Chin; Karen Miotto
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

4.  Non-specific effect of naltrexone on ethanol consumption in social drinkers.

Authors:  H de Wit; J Svenson; A York
Journal:  Psychopharmacology (Berl)       Date:  1999-09-01       Impact factor: 4.530

5.  Drinking to cope with negative affect and DSM-IV alcohol use disorders: a test of three alternative explanations.

Authors:  K M Carpenter; D S Hasin
Journal:  J Stud Alcohol       Date:  1999-09

6.  Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts.

Authors:  A Ferrari; M Bertolotti; A Dell'Utri; U Avico; E Sternieri
Journal:  Drug Alcohol Depend       Date:  1998-11-01       Impact factor: 4.492

7.  Naltrexone in the treatment of alcohol dependence.

Authors:  J R Volpicelli; A I Alterman; M Hayashida; C P O'Brien
Journal:  Arch Gen Psychiatry       Date:  1992-11

8.  Effects of childhood maltreatment on the neural correlates of stress- and drug cue-induced cocaine craving.

Authors:  Amanda Elton; Sonet Smitherman; Jonathan Young; Clinton D Kilts
Journal:  Addict Biol       Date:  2014-09-11       Impact factor: 4.280

9.  Impulse control disorders: updated review of clinical characteristics and pharmacological management.

Authors:  Liana Schreiber; Brian L Odlaug; Jon E Grant
Journal:  Front Psychiatry       Date:  2011-02-21       Impact factor: 4.157

10.  rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex.

Authors:  Sang Soo Cho; Antonio P Strafella
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

View more
  2 in total

1.  A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.

Authors:  T Jordan Walter; Montserrat Navarro; Todd E Thiele; Cort Pedersen; Alexey Kampov-Polevoy; J C Garbutt
Journal:  Alcohol Alcohol       Date:  2020-02-07       Impact factor: 3.913

2.  Opioid antagonism modulates wanting-related frontostriatal connectivity.

Authors:  Alexander Soutschek; Susanna C Weber; Thorsten Kahnt; Boris B Quednow; Philippe N Tobler
Journal:  Elife       Date:  2021-11-11       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.